T
TubeFolio
Back to Dashboard

Terrible News for FICO Stock Investors

Summary

Parkev analyzes the impact of the Federal Housing Finance Agency's decision to include VantageScore in mortgage pricing, effectively ending FICO's decades-long monopoly in the sector. This news caused FICO shares to drop over 26%, contributing to a year-to-date decline of more than 63%. Parkev points out that the stock is now trading at a forward price-to-earnings (P/E) ratio of 11.6, its lowest valuation in history. Parkev notes that such a valuation is typically reserved for stagnant companies, yet Wall Street analysts still forecast strong revenue growth of 28% for the current fiscal year, followed by 14% and 12% in the subsequent years.

To account for the new competitive risks, Parkev updated his valuation model by increasing the Beta from a historical 1.32 to a more conservative 1.75. Even with this higher risk profile, Parkev finds the stock to be approximately 18% undervalued. Parkev highlights that if the original Beta of 1.32 were applied, the fair value would exceed $1,045 per share, representing over 69% upside. While acknowledging the risk of FICO becoming a value trap if revenue growth stalls, Parkev concludes that the current price offers a significant opportunity for those willing to weather the increased volatility.

FICO (Fair Isaac Corporation): Parkev views the stock as a buy because the market has overreacted to the loss of its monopoly. Despite the increased competition from VantageScore, Parkev emphasizes that the company's valuation has reached a historic low while growth expectations remain in the double digits. Parkev calculates that even with a higher risk adjustment (Beta of 1.75), the stock has an 18% upside potential.

Mentioned Stocks

FICO
Sentiment: BUYAction: RECOMMENDED

Reasoning: Parkev confirms a buy recommendation for FICO, noting its record-low forward P/E of 11.6. Parkev argues that the market's reaction to the FHFA's inclusion of VantageScore is excessive given the projected revenue growth of 28% this year and double-digits in the following years. Parkev adjusted the risk Beta from 1.32 to 1.75 to be conservative, which still results in an 18% upside; using the previous Beta of 1.32 would suggest a price target over $1,045.

Loading chart...